Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Researchers hope to combine gene editing with a less toxic stem cell transplant. Findings may apply to cancer and other illnesses.
The new drug improved overall survival for people who could not complete curative chemotherapy.
More than 80% of clinical trial participants experienced complete or partial remission.
New drugsto treat multiple myeloma are producing better results for patients, with fewer side effects.
KTE-X19 led to durable remission in a majority of study participants.
I think about my birthday differently ever since my diagnosis of stage IIA invasive lobular breast cancer.
This represents an important advance for patients who previously needed to visit a health care facility.
Hispanic blood cancer patients living at the U.S./Mexico border may have lower overall survival than those who live in other parts of Texas.
After Erica Campbell was diagnosed with Stage IV Hodgkin lymphoma, she could barely stand. Now she’s walking runways as a plus-size model.
Pam Dobay has endured a lot in the last three years.
Mylotarg consists of an antibody that binds to the CD33 receptor protein on malignant B cells combined with a chemotherapy drug.
September was designated as National Blood Cancer Awareness Month in 2010 by United States Congress.
Data from a large COVID-19 and cancer registry also showed that hydroxychloroquine plus azithromycin is associated with higher mortality.
A clinical trial will test whether Imbruvica can protect against respiratory problems caused by the virus.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.